|
Name |
Isobutyramide
|
Molecular Formula | C4H9NO | |
IUPAC Name* |
2-methylpropanamide
|
|
SMILES |
CC(C)C(=O)N
|
|
InChI |
InChI=1S/C4H9NO/c1-3(2)4(5)6/h3H,1-2H3,(H2,5,6)
|
|
InChIKey |
WFKAJVHLWXSISD-UHFFFAOYSA-N
|
|
Synonyms |
Isobutyramide; 563-83-7; 2-Methylpropanamide; 2-Methylpropionamide; Propanamide, 2-methyl-; Isobutyrimidic acid; Isobutylamide; MFCD00008019; 82UOE7B38Z; NSC-8423; dimethylacetoamide; NSC 8423; EINECS 209-265-9; BRN 1737615; UNII-82UOE7B38Z; C-isopropylformamide; 2-methyl-propanamide; isobutyric acid amide; Isobutyramide, 99%; CRYSTALPONCEAU6R; 1-carbamoyl-1-methylethyl; 4-02-00-00852 (Beilstein Handbook Reference); 68424-61-3; CHEMBL352219; Glycerides, C16-18 and C18-unsatd. mono- and di-; DTXSID1060340; NSC8423; CHEBI:193555; ZINC1484944; BDBM50224866; AKOS001084432; CS-W019979; NCI60_041854; SY015332; DB-052904; DB-072139; FT-0627380; FT-0672107; I0102; EN300-17833; W-105521; Q10859786; Z57046209; IBO
|
|
CAS | 563-83-7 | |
PubChem CID | 68424 | |
ChEMBL ID | CHEMBL352219 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 87.12 | ALogp: | 0.2 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 43.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 6 | QED Weighted: | 0.498 |
Caco-2 Permeability: | -4.556 | MDCK Permeability: | 0.00021824 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.419 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.997 | Plasma Protein Binding (PPB): | 21.58% |
Volume Distribution (VD): | 0.958 | Fu: | 76.04% |
CYP1A2-inhibitor: | 0.221 | CYP1A2-substrate: | 0.258 |
CYP2C19-inhibitor: | 0.03 | CYP2C19-substrate: | 0.587 |
CYP2C9-inhibitor: | 0.007 | CYP2C9-substrate: | 0.162 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.281 |
CYP3A4-inhibitor: | 0.008 | CYP3A4-substrate: | 0.249 |
Clearance (CL): | 8.033 | Half-life (T1/2): | 0.32 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.06 |
Drug-inuced Liver Injury (DILI): | 0.042 | AMES Toxicity: | 0.032 |
Rat Oral Acute Toxicity: | 0.026 | Maximum Recommended Daily Dose: | 0.019 |
Skin Sensitization: | 0.125 | Carcinogencity: | 0.034 |
Eye Corrosion: | 0.072 | Eye Irritation: | 0.943 |
Respiratory Toxicity: | 0.021 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000149 | 0.529 | D09PUL | 0.368 | ||||
ENC000376 | 0.500 | D02XBW | 0.313 | ||||
ENC000382 | 0.429 | D07ZTO | 0.290 | ||||
ENC000186 | 0.375 | D00ZOF | 0.286 | ||||
ENC000010 | 0.368 | D08QGD | 0.286 | ||||
ENC000237 | 0.364 | D00WUF | 0.281 | ||||
ENC000351 | 0.364 | D0ZK8H | 0.269 | ||||
ENC000771 | 0.346 | D01BQK | 0.263 | ||||
ENC000824 | 0.333 | D07CWD | 0.263 | ||||
ENC000246 | 0.320 | D08HZC | 0.259 |